Transaction · 0000920148-26-000086

Schechter Adam H

Schechter Adam H, PRES, CEO, reported an open-market or private sale at LABCORP HOLDINGS INC. involving 5273.000000 shares for an estimated $1499535.74. Reported holdings after the transaction were 87343.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SPRES, CEO
LHLABCORP HOLDINGS INC.
Filing timeFeb 13
Trade dateFeb 11, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$282.63
Pre-filing
1mo ago -11.4%1w ago -2.3%1d ago +0.7%
Returns since
7d +0.0%30d -6.7%90d -10.1%180d +14.5%1y +18.1%

LH price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
LH since 2026-02-13Filed 204 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000920148-26-000086
Common Stock
Transaction date
Feb 11, 2026
Filed Feb 13, 2026, 06:13 PM · 2d delay
Shares
5.27k sh
$28.4k per share
Estimated value
-$149M
Computed from shares × price
Holdings after
87.3k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Large Sale 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President & CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

  2. F2

    Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

  3. F3

    Stock withholding to satisfy tax withholding obligations.

  4. F4

    The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

  5. F5

    This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Original filing · 0000920148-26-000086
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

LH